These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12807348)

  • 61. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.
    Ihl R; Tribanek M; Bachinskaya N
    J Neurol Sci; 2010 Dec; 299(1-2):184-7. PubMed ID: 20837354
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2015; 43(2):589-603. PubMed ID: 25114079
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The ABC of Alzheimer's disease: behavioral symptoms and their treatment.
    Grossberg GT
    Int Psychogeriatr; 2002; 14 Suppl 1():27-49. PubMed ID: 12636179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Strategies for the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Chan YF; Chen C; Dasig D; Dominguez J; Han SH; Jia J; Kim S; Limpawattana P; Ng LL; Nguyen DT; Ong PA; Raya-Ampil E; Saedon N; Senanarong V; Setiati S; Singh H; Suthisisang C; Trang TM; Turana Y; Venketasubramanian N; Yong FM; Youn YC; Ihl R
    CNS Neurosci Ther; 2021 Feb; 27(2):149-162. PubMed ID: 33352000
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rivastigmine for dementia associated with Parkinson's disease.
    Emre M; Aarsland D; Albanese A; Byrne EJ; Deuschl G; De Deyn PP; Durif F; Kulisevsky J; van Laar T; Lees A; Poewe W; Robillard A; Rosa MM; Wolters E; Quarg P; Tekin S; Lane R
    N Engl J Med; 2004 Dec; 351(24):2509-18. PubMed ID: 15590953
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial.
    Woelk H; Arnoldt KH; Kieser M; Hoerr R
    J Psychiatr Res; 2007 Sep; 41(6):472-80. PubMed ID: 16808927
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders.
    Le Bars PL
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S44-9. PubMed ID: 13130388
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacologic treatment of Alzheimer's disease: an update.
    DeLaGarza VW
    Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cholinesterase inhibitors for Parkinson's disease dementia.
    Maidment I; Fox C; Boustani M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence-based pharmacotherapy of Alzheimer's disease.
    Evans JG; Wilcock G; Birks J
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):351-69. PubMed ID: 15228642
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic efficacy of the Ginkgo special extract EGb761
    Müller WE; Eckert A; Eckert GP; Fink H; Friedland K; Gauthier S; Hoerr R; Ihl R; Kasper S; Möller HJ
    World J Biol Psychiatry; 2019 Mar; 20(3):173-189. PubMed ID: 28460580
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
    Robert P
    Curr Med Res Opin; 2002; 18(3):156-71. PubMed ID: 12094826
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
    Mix JA; Crews WD
    J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term treatment with standardized Ginkgo biloba extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia.
    Rocher MN; Carré D; Spinnewyn B; Schulz J; Delaflotte S; Pignol B; Chabrier PE; Auguet M
    Fitoterapia; 2011 Oct; 82(7):1075-80. PubMed ID: 21820038
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine.
    Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E
    Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.
    Le Bars PL
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S50-5. PubMed ID: 13130389
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rivastigmine for Alzheimer's disease.
    Birks J; Iakovidou V; Tsolaki M
    Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Pharmaco-economic evaluation of Ginkgo special extract EGb 761 for dementias in Austria].
    Hörr R; Kieser M
    Wien Med Wochenschr; 2002; 152(15-16):427-31. PubMed ID: 12244892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.